Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with a specific type of breast cancer (invasive ductal carcinoma) at certain stages (cT1-3N1) who are planned to receive chemotherapy and/or targeted therapy before surgery
- People who are mentally able to understand and give consent to participate
- People who have agreed to go ahead with surgery aimed at curing the cancer after chemotherapy, and who are open to a type of surgery that preserves most of the breast, along with a targeted procedure to check nearby lymph nodes
- People where imaging scans and tissue testing (cytology or biopsy) have confirmed that 1 to 3 lymph nodes under the arm on the same side as the cancer are affected
Who may not be able to join:
- People whose cancer has spread to other parts of the body, or who have a fast-spreading type called inflammatory breast cancer, or cancer in more than one area of the same breast
- People who have previously had surgery or radiation treatment to the armpit area on the same side as the cancer
- People with a known sensitivity or allergic reaction to dextran compounds or iron
- People with a condition that causes too much iron to build up in the body
- People who are pregnant or currently breastfeeding
- People who have a pacemaker, other metal implants in the chest wall, or a joint replacement in the shoulder
- People who are not mentally able to give informed consent (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 852-25898116
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Successful localization of breast tumor and axillary lymph node
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.